Dipeptidyl peptidase-4(DPP-4)inhibitors can effectively improve blood glucose control in individuals with T2DM and notably decrease glucose variability when compared to alternative oral medications for diabetes (12, 13). This evidence concerns the gene DPP4 and diabetes mellitus.